Filing Flows › Core Laboratories (CLB) › Stock forecast & fair value
Core Laboratories (CLB) stock forecast and price target
Core Laboratories (CLB) trades at $8.84. 3 analysts' median price target is $13.00 (+47%), from $11.00 to $21.00.
Core Laboratories' latest quarter
Core Laboratories, Q3 2026: revenue $132M (-2% year over year), operating margin 9.1%, net earnings $5.4M, operating cash flow $5.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for CLB stock?
The median of 3 analysts' 12-month targets is $13.00, +47% from $8.84; the range is $11.00 to $21.00. The average rating is buy.
Does Core Laboratories usually beat earnings estimates?
It beat the consensus EPS estimate in 60% of the quarters on record.
Is CLB stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.